Languages:
PT-BR
|
EN-US
|
ES
BLAU
ABOUT US
PURPOSE AND VALUES
OUR BUSINESS UNITS
OUR HISTORY
AWARDS AND RECOGNITIONS
EVENTS
PRESS ROOM
EXECUTIVE BOARD AND BOARD OF DIRECTORS
CORPORATE STRUCTURE
OWNERSHIP BREAKDOWN
CERTIFICATIONS
INTERNATIONALIZATION
INTERNATIONALIZATION
BRAZIL
ARGENTINA
URUGUAI
COLÔMBIA
PERÚ
CHILE
USA
PHARMA TECH
BIOTECHNOLOGY
INVENTTA RD&I
ESG
OVERVIEW
SUSTAINABILITY
COMPLIANCE
PRODUCTS
QUALITY POLICY
ALL THE PRODUCTS
INVESTORS
CUSTOMER CHANNEL
VERIFICATION OF ELECTRONIC REPORT
CLINICAL RESEARCH
BIOEQUIVALENCE
USEFUL LINKS
ARTICLE
BE BLAUER
RELATÓRIO DE IGUALDADE E TRANSPARÊNCIA SALARIAL
JOIN OUR TEAM
BLAU BY BLAUERS
CONTACTS
PAS/CS
BUSINESS DEVELOPMENT
PHARMACOVIGILANCE
BUSINESS UNITS
Languages:
PT-BR
|
EN-US
|
ES
ARTICLE
HOME
CUSTOMER CHANNEL
ARTICLE
Biosimilar Filgrastim for Progenitor-Cell Mobilization prior to Autologous Transplantation:Retrospective Analysis of Patients with Multiple Myeloma and Lymphomas